Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Masimo Corp (MASI)

Masimo Corp (MASI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,713,735
  • Shares Outstanding, K 53,337
  • Annual Sales, $ 937,840 K
  • Annual Income, $ 196,220 K
  • 60-Month Beta 0.80
  • Price/Sales 10.45
  • Price/Cash Flow 47.27
  • Price/Book 8.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.88
  • Number of Estimates 2
  • High Estimate 0.88
  • Low Estimate 0.88
  • Prior Year 0.79
  • Growth Rate Est. (year over year) +11.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
143.90 +28.37%
on 03/18/20
188.03 -1.76%
on 04/06/20
+4.72 (+2.62%)
since 03/06/20
3-Month
143.90 +28.37%
on 03/18/20
188.03 -1.76%
on 04/06/20
+26.40 (+16.68%)
since 01/06/20
52-Week
118.93 +55.32%
on 04/18/19
188.03 -1.76%
on 04/06/20
+48.92 (+36.02%)
since 04/05/19

Most Recent Stories

More News
Nevro (NVRO) Looks Good: Stock Adds 6.5% in Session

Nevro (NVRO) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

MASI : 184.61 (+1.37%)
NVRO : 101.88 (+8.43%)
Innovative Wearable Tech Gives Doctors a New Approach to Patient Care

The healthcare industry has made significant progress when it comes to efficiency and scope in the last several years, yet many complex issues remain unsolved. However, wearable devices provide an innovative...

NMRD : 5.35 (-1.65%)
MASI : 184.61 (+1.37%)
ABT : 81.85 (+3.02%)
APT : 15.00 (-5.18%)
HOLX : 35.71 (+8.81%)
Masimo Announces Preliminary, Unaudited First Quarter 2020 Product Revenue

Masimo Corporation (Nasdaq: MASI) today announced a preliminary product revenue range for the first quarter ended March 28, 2020, and provided a business update regarding the impact of the Coronavirus...

MASI : 184.61 (+1.37%)
Is Masimo (MASI) Stock Outpacing Its Medical Peers This Year?

Is (MASI) Outperforming Other Medical Stocks This Year?

MASI : 184.61 (+1.37%)
Study Finds Zero Patient Deaths from Opioid-Induced Respiratory Depression Over 10 Years with Masimo SET(R) and Masimo Patient SafetyNet(TM) Technology

Masimo (NASDAQ: MASI) today announced the results of a recently published ten-year retrospective study in which researchers at Dartmouth-Hitchcock Medical Center investigated the impact of an integrated...

MASI : 184.61 (+1.37%)
Here's Why Investors Should Buy Masimo (MASI) Stock Now

Masimo (MASI) sees a slew of developments lately.

SYK : 164.21 (+10.90%)
ARAY : 1.9100 (+10.40%)
MASI : 184.61 (+1.37%)
COO : 294.32 (+5.23%)
Masimo & University Hospitals Unite for Patient Monitoring

Masimo (MASI) sees a plethora of developments lately.

SYK : 164.21 (+10.90%)
ARAY : 1.9100 (+10.40%)
MASI : 184.61 (+1.37%)
COO : 294.32 (+5.23%)
Masimo and University Hospitals Jointly Announce Masimo SafetyNet(TM), a New Remote Patient Management Solution Designed to Aid COVID-19 Response Efforts

Masimo (NASDAQ: MASI) and University Hospitals (UH), one of the largest health systems in Northeast Ohio, today jointly announced Masimo SafetyNet(TM), an innovative, economically scalable patient management...

MASI : 184.61 (+1.37%)
In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow(R) Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb(R), at No Additional Charge During the Coronavirus Pandemic

Masimo (NASDAQ: MASI) today announced that, in response to current worldwide blood shortages driven by the coronavirus pandemic, it is making rainbow(R) licenses available for no additional charge to hospitals...

MASI : 184.61 (+1.37%)
In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow(R) Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb(R), at No Additional Charge During the Coronavirus Pandemic

Masimo (NASDAQ: MASI) today announced that, in response to current worldwide blood shortages driven by the coronavirus pandemic, it is making rainbow(R) licenses available for no additional charge to hospitals...

MASI : 184.61 (+1.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade MASI with:

Business Summary

Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare...

See More

Key Turning Points

2nd Resistance Point 188.06
1st Resistance Point 185.09
Last Price 184.61
1st Support Level 179.57
2nd Support Level 177.03

See More

52-Week High 188.03
Last Price 184.61
Fibonacci 61.8% 161.63
Fibonacci 50% 153.48
Fibonacci 38.2% 145.33
52-Week Low 118.93

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar